![]() |
Volumn 455, Issue , 1999, Pages 295-298
|
Enalapril (10mg/day) in systemic sclerosis: One year, double blind, randomised study (ESS-1): Electrocardiographic substudy - Three months follow-up
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
IMMUNOSUPPRESSIVE AGENT;
PLACEBO;
ADULT;
CARDIOPULMONARY HEMODYNAMICS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
ELECTRIC POTENTIAL;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIGNAL AVERAGED ELECTROCARDIOGRAPHY;
SYSTEMIC SCLEROSIS;
TREATMENT OUTCOME;
ARTICLE;
ELECTROCARDIOGRAPHY;
FIBROSIS;
MIDDLE AGED;
PATHOPHYSIOLOGY;
ADULT;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
DOUBLE-BLIND METHOD;
ELECTROCARDIOGRAPHY;
ENALAPRIL;
FEMALE;
FIBROSIS;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
SCLERODERMA, SYSTEMIC;
|
EID: 0033233106
PISSN: 00652598
EISSN: None
Source Type: Book Series
DOI: 10.1007/978-1-4615-4857-7_43 Document Type: Conference Paper |
Times cited : (2)
|
References (9)
|